Skip to main content
BURCON NUTRASCIENCE CORPORATION logo

BURCON NUTRASCIENCE CORPORATION — Investor Relations & Filings

Ticker · BU ISIN · CA1208313009 LEI · 391200FXBJCM5THDSO98 TSX Manufacturing
Open in API
Filings indexed 257 across all filing types
Latest filing 2026-04-27 Capital/Financing Update
Country CA Canada
Listing TSX BU

About BURCON NUTRASCIENCE CORPORATION

https://burcon.ca/

Burcon NutraScience Corporation is a global technology leader focused on the development and commercialization of high-purity, plant-based protein ingredients for the food and beverage industry. The company utilizes proprietary processing technologies and a portfolio of over 290 issued patents to create best-in-class protein solutions known for superior functionality, exceptional taste, and high nutritional value. Burcon's ingredient portfolio includes uniquely soluble Pea Protein, high-purity Fava Protein isolate, and the world's first highly functional food-grade Canola Protein. Operating a technical center and semi-works production facility, Burcon serves as a development partner for manufacturers seeking innovative and sustainable protein alternatives for products such as dairy alternatives.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release announcing the closing of the final tranche of a non-brokered private placement of convertible debentures and details the terms, insider participation, and use of proceeds. This is a financing update regarding company capital raising activities. According to the filing definitions, this falls under “Capital/Financing Update” (CAP).
2026-04-27 English
News release - English.pdf
Regulatory Filings
2026-04-20 English
News release - English.pdf
Regulatory Filings
2026-04-20 English
News release - English.pdf
Earnings Release Classification · 1% confidence The document is a press release titled 'Burcon Announces Fiscal 2026 Third Quarter Results'. It provides a summary of financial highlights, management commentary, and key operational updates for the quarter ended December 31, 2025. While it contains some financial tables, it is primarily an initial announcement of quarterly results rather than the full interim report itself, and it explicitly directs readers to the full financial statements and MD&A filed on SEDAR+. Therefore, it is classified as an Earnings Release. Q3 2026
2026-02-11 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a 'Form 52-109F2', which is a standard officer certification of interim filings. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a report (like an interim report), should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive financial data. Q3 2025
2026-02-11 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a 'Form 52-109F2', which is a standard Canadian securities regulatory form for the certification of interim filings by a CEO. According to the 'CERTIFICATION RULE' provided in the instructions, documents that are primarily officer certifications or attestations, even if they reference a specific report type (like interim filings), must be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive financial data. Q3 2025
2026-02-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.